In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1932 News Items found
A pink smoothie is poured from a pitcher into a glass
Study Suggests Sugar Can Worsen Common Intestinal Side Effect of Antibiotics

A new study found that consuming high levels of sugar while taking antibiotics appears to worsen common gastrointestional side effects in patients receiving bone marrow transplants.
The co-leaders of the MSK Lobular Breast Cancer program are seen together.
What Is Invasive Lobular Carcinoma? MSK Doctors Explain

Learn how MSK’s Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC, as well as the latest treatment and research.
Surgeon-scientist Vinod Balachandran in the laboratory
Q&A
What To Know About Pancreatic Cancer

Learn about important advances in the treatment of pancreatic cancer.
Dr. Robert Motzer
FDA Approves Belzutifan + Lenvatinib for Clear Cell Kidney Cancer

The FDA has approved a new drug combination for treating advanced kidney cancer — belzutifan + lenvatinib — based on research led by a doctor at MSK.
scientific image of lung cancer
Using Nanoparticles To Target Fibrosis in Cancer and Other Diseases

Scientists at MSK have developed a new nanoparticle-based approach to breaking down fibrosis in cancer and other diseases, which could make immunotherapy more effective. Learn about their findings in laboratory models.
Family of four sitting and smiling for camera.
Metastatic Breast Cancer and Motherhood

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.
Agnel Sfeir
Scientists Uncover an Achilles’ Heel in Cancer’s ‘Rogue DNA’

MSK researchers have discovered that a type of rogue DNA found in aggressive cancers has a hidden structural weakness — and that blocking a single repair protein can cause it to fall apart, suggesting a new therapeutic opportunity.
MSK breast cancer specialist Pedram Razavi, MD, PhD.
Article
Latest Research Into Overcoming Resistance to Breast Cancer Targeted Therapies

Learn how MSK's researchers are making important strides in overcoming breast cancer resistance.
MSK medical oncologist Komal Jhaveri
Article
FDA Expands Approval for Imlunestrant To Treat ER+, HER2-, ESR1-mutated Advanced Breast Cancer That Resists Standard Therapy

Read about a new FDA-approved treatment for people with some ER+, HER2- advanced breast cancers.
GSK student Zaza Gelashvili
2026 GSK Chairman’s Prize Recognizes Research on How Cells Sense Injury

This year's GSK Chairman’s Prize was awarded to Zaza Gelashvili for his research on how cells sense injury.